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Zampanolide and its less active analog dactylolide
compete with paclitaxel for binding to microtubules
and represent a new class of microtubule-stabilizing
agent (MSA). Mass spectrometry demonstrated
that the mechanism of action of both compounds
involved covalent binding to b-tubulin at residues
N228 and H229 in the taxane site of the microtubule.
Alkylation of N228 and H229 was also detected in
a,b-tubulin dimers. However, unlike cyclostreptin,
the other known MSA that alkylates b-tubulin, zam-
panolide was a strong MSA. Modeling the structure
of the adducts, using the NMR-derived dactylolide
conformation, indicated that the stabilizing activity
of zampanolide is likely due to interactions with the
M-loop. Our results strongly support the existence
of the luminal taxane site of microtubules in tubulin
dimers and suggest that microtubule nucleation
induction by MSAs may proceed through an allo-
steric mechanism.
INTRODUCTION
Increasing life expectancy by improved vaccination and hygienic
practices has placed neoplastic diseases at the forefront in the
major causes of mortality. Among treatment options, chemo-
therapy is commonly employed and often successful.
Chemotherapy employs a chemical agent that is selective
for different cell types deriving from differences in the biology686 Chemistry & Biology 19, 686–698, June 22, 2012 ª2012 Elsevierof the body’s cells. A major difference between cancer cells
and most healthy cells is that transformed cells divide much
faster. Because of this, tubulin, the main component of the
microtubule (MT) cytoskeleton, is an obvious target for
compounds designed to block cell division. MTs are highly
dynamic in mitosis, and therefore, dividing cells are particularly
susceptible to agents that target tubulin (Dumontet and
Jordan, 2010).
MT-stabilizing agents (MSAs) promote MT assembly by
blocking disassembly of the guanosine-diphosphate (GDP)-
bound form of tubulin and promoting assembly of the guano-
sine-triphosphate (GTP)-bound form. Among MSAs, paclitaxel
(PTX) and docetaxel (DCX) are two very efficacious chemother-
apeutic agents. Widely used for the treatment of breast,
ovarian, and lung cancer, their clinical use is, however,
severely hampered by low solubility and the development of
resistance by the target cells due to overexpression of both
the P-glycoprotein (P-gp) drug efflux pump and bIII-tubulin.
Thus, compounds that are less susceptible to P-gp drug efflux
may have novel pharmacokinetic and pharmacodynamic
profiles, including the potential for oral administration (Dumon-
tet and Jordan, 2010). Tubulin modulators devoid of the
problem of P-gp-mediated drug efflux are thus needed. A large
number of compounds with MSA activity have been investi-
gated in this context. Among these compounds, cyclostreptin
(CS) (Edler et al., 2005; Sato et al., 2000) has a novel mecha-
nism of action. By covalently binding to tubulin, CS overcomes
P-gp-mediated multidrug resistance (MDR) (Buey et al., 2007);
however, its high chemical instability and low potency preclude
its use as a lead compound. Nevertheless, an interesting
feature of CS binding is that it occurs, at least partially, at
the type I pore of MTs, a fenestration in the MT wall close to
the PTX site. The pore thus contains a transient binding siteLtd All rights reserved
Figure 1. Chemical Structures of ZMP and
DAC and Their Effects on Lung Carcinoma
Cells
(A–D) Cellular effects of DAC and natural and
synthetic ZMP on the MT network, nuclear
morphology, and cell cycle of A549 lung carci-
noma cells. Micrographs of A549 cells incubated
for 24 hr with DMSO (A), 10 mM DAC (B), 50 nM
synthetic ZMP (C), and 100 nM PTX (D). MTs
(green) were shown by immunostaining with an
a-tubulin monoclonal antibody, and DNA (blue)
was shown by staining with Hoechst 33342. Insets
are mitotic spindles from the same preparation.
The scale bar represents 10 mm.
(E–H) Effect of the compounds on the cell cycle of
A549 cells as measured by flow cytometry. Cells
were treated with DMSO (E), 10 mMDAC (F), 10 nM
synthetic ZMP (G), or 20 nM PTX (H). The graphs
show the proportions between cells in the G0/G1
phase of the cell cycle and those in the G2/M
phase, which in the compound-treated cells
contain double the amount of DNA.
Chemistry & Biology
Zampanolide Mechanism of Actionfor taxanes (Buey et al., 2007; Dı´az et al., 2003) on their way to
the luminal site (Nogales et al., 1999). Binding to the pore
produces the same cytotoxic effects as binding to the luminal
site (Barasoain et al., 2010), indicating that this pore site can
be probed as a new druggable binding site on the MT. Binding
to these two sites on b-tubulin, moreover, is mutually exclusive
(Dı´az et al., 2005). The third MSA site is entirely distinct
from the taxane site and is targeted by the natural products
laulimalide (LAU) and peloruside A (PLA) (Bennett et al.,
2010; Khrapunovich-Baine et al., 2011; Pera et al., 2010; Pryor
et al., 2002).
Zampanolide (ZMP) is a novel MSA chemotype originally
isolated in 1996 from the marine sponge Fasciospongia rimosa
(Tanaka and Higa, 1996). The compound has a highly unsatu-
rated, 20-membered macrolide ring and an N-acyl hemiaminal
side chain (Figure 1). Field et al. (2009) discovered that thisChemistry & Biology 19, 686–698, June 22, 2012new cytotoxic chemotype targeted
tubulin and that its mechanism of action
was that of an MSA, promoting tubulin
assembly and blocking cells in G2/M of
the cell cycle (Field et al., 2009).
The macrolide (+)-dactylolide (DAC)
(Figure 1) was isolated from the sponge
Dactylospongia sp. (Cutignano et al.,
2001). (+)-DAC is structurally related to
()-ZMP, but the two compounds have
opposite absolute configurations of their
otherwise identical macrolactone core.
In this work, we investigated the
nonnatural enantiomer ()-DAC for
comparison with ()-ZMP for its cyto-
toxic and antitubulin properties, since
()-DAC lacks only the hemiaminal
side chain of ()-ZMP. In this study,
we investigated the location of the
ZMP/DAC binding site on MTs, theirmechanism of binding, and the conformation of the bound
()-DAC.
RESULTS
Cellular Activity of the Compounds and Comparison
of Natural and Synthetic ZMP
The activities of natural and synthetic ZMP and synthetic DAC
were tested. Both ZMP preparations had equivalent cytotoxicity
for A2780 cells in the nM range, while DAC was cytotoxic in the
low-mM range (Table 1). ZMP and DAC were equally active in
sensitive (A2780) and MDR cells (A2780AD). Synthetic ZMP
(50 nM) induced abundant, characteristic short MT bundles in
A549 cells; in comparison, bundles in cells treated with 100 nM
PTX or 10 mM DAC were longer and less abundant (Figures
1A–1D). In all cases micronucleated cells were observed.ª2012 Elsevier Ltd All rights reserved 687
Table 1. Cytotoxicity of DAC and Natural and Synthetic ZMP on
the Growth of Two Human Ovarian Carcinoma Cell Lines
Compound A2780 (nM)a A2780AD (nM)a R/Sb
Natural ZMPc 1.9 ± 0.2 2.2 ± 0.3 1.2
Synthetic ZMP 1.4 ± 0.3 1.5 ± 0.4 1.1
DAC 602 ± 100 1236 ± 180 2.1
PTX 0.46 ± 0.10 1065 ± 101 2315
IC50 values of the ligands determined in ovarian carcinoma cells A2780
and P-gp-overexpressing A2780AD cells.
aIC50 values (nM) are the mean ± SEM of three independent assays.
bThe relative resistance of the A2780AD cell line obtained by dividing the
IC50 of the resistant cell line by that of the parental A2780 cell line.
cPreviously determined IC50 values of natural ZMP (Field et al., 2009) in
A2780 and A2780AD cells were 7.1 ± 0 nM and 7.5 ± 0.6 nM, respectively.
The difference could be caused by assay differences.
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Zampanolide Mechanism of ActionLikewise, at the above doses, PTX and DAC induced aberrant
mitotic spindles that were mostly mono- or bipolar. With ZMP,
the aberrant mitotic cells mostly displayed multiple asters.
When A549 cells were incubated for 20 hr with serial dilutions
of these drugs, maximal drug effects (more than 90% of the cells
in the G2/M phase of the cell cycle) occurred with 10 mM DAC,
10 nM ZMP, or 20 nM PTX (Figures 1E–1H).
ZMP Binds Irreversibly to Tubulin, Stoichiometrically
Inducing Its Assembly in a PTX-like Manner
Strong MSAs that bind to the PTX or the LAU/PLA site stoichio-
metrically promote MT assembly in conditions where MT
assembly either does not occur or is inhibited (Mooberry et al.,
1999; Parness and Horwitz, 1981; Pera et al., 2010). The ability
of both natural and synthetic ZMP to promote MT assembly
was tested in PEDTA4 buffer (10 mM NaPi, 1 mM EDTA, 4 mM
MgCl2, 1 mM GTP at pH 6.7). In this buffer, tubulin is unable to
assemble unless a strong MSA is present. In these conditions,
ZMP was able to induce assembly of tubulin with a critical
concentration (Cr) (Oosawa and Asakura, 1975) of 4.1 mM,
requiring little excess compound to induce maximal assembly
(Figure 2A). The assembled polymers were found to be MTs by
electron microscopy (Figure 2A, inset). Natural and synthetic
ZMP behaved identically.
Under conditions in which tubulin is able to assemble without
an MSA (3.4 M glycerol, 10 mM NaPi, 1 mM EGTA, 6 mMMgCl2
buffer [pH 6.7; GAB buffer] + 1 mMGTP), ZMP was a very strong
assembly inducer (Cr = 0.81 ± 0.16 mM), with potency similar to
that of DCX (Cr = 0.65 ± 0.05 mM). DAC also significantly
enhanced tubulin assembly, reducing the Cr measured in the
absence of ligand (3.3 ± 0.30 mM) by roughly 30% (Cr = 2.10 ±
0.15 mM) to the level of other weak assembly inducers (sarcodic-
tyins A and B; CS) (Buey et al., 2005). Moreover, it was not
possible to extract ZMP or DAC from the MT pellets, suggesting
that these compounds bind to tubulin in an irreversible manner.
Other MSAs, such as PTX or PLA, which are reversible binders,
are easily recovered from MT pellets (Dı´az and Andreu, 1993;
Pera et al., 2010).
To check ZMP binding to tubulin with a direct binding assay,
either 25 mM PTX binding sites in crosslinked, stabilized MTs
were incubated with substoichiometric (20 mM) amounts of
ZMP or DAC, or MT formation was induced by 20 mM compound688 Chemistry & Biology 19, 686–698, June 22, 2012 ª2012 Elsevierin conditions in which tubulin can self-assemble (25 mM in GAB
buffer). In the absence of stabilized MTs or tubulin, both DAC
and ZMP at 20 mM were recovered from the supernatant.
However, in the presence of stabilized or native assembled
MTs, ZMP could not be extracted from supernatants or pellets,
indicating irreversible binding within 30 min. DAC behaved simi-
larly, but at least 4 hr were required for a complete reaction.
Thus, the kinetic rate of the DAC interaction is much slower
than the ZMP interaction.
The stoichiometry of the reaction was determined by incu-
bating 25 mM PTX binding sites in crosslinked, stabilized MTs
with increasing amounts of ZMP or DAC (Figure 2B). The
25 mM PTX binding sites can react with up to 25 mM ZMP or
DAC, and all the excess remains in the supernatant, thus indi-
cating that the interaction of ZMP and DAC with MTs proceeds
with a 1:1 stoichiometry.
ZMP and Its Analogs were PTX Biomimetics and Did Not
Interfere with PLA Binding
In an initial experiment, ZMP was evaluated for potential inhibi-
tion of the binding of [3H]PTX and/or [3H]PLA to preformed
MTs. ZMP strongly inhibited PTX binding (67% inhibition), but
not PLA binding (13% inhibition) (control experiments showed
that discodermolide inhibited 91% of PTX binding and 12% of
PLA binding, while LAU inhibited 90% of PLA binding but not
PTX binding). Thus, we concluded that ZMP, and presumably
DAC, are new agents that bind to the same site on MTs as PTX.
The compounds were therefore tested for their ability to
displace Flutax-2, a fluorescent PTX biomimetic, from stabilized,
crosslinked MTs (Buey et al., 2005). ZMP and DAC were
compared with DCX and epothilone A. All four compounds
tested displaced Flutax-2 from its binding site (Figure 2C), with
different apparent binding affinities. The apparent binding
constant of ZMP at 35C (2143 106 M1) was 150 times greater
than that of DAC (1.35 3 106 M1), indicating a strong influence
of the side chain on the binding reaction (Table S1 available
online). The apparent binding constants of the compounds
increased with temperature (ZMP Kbap26
C = 137 ± 29 3
106 M1, Kbap42C = 424 ± 175 3 10
6 M1; DAC Kbap26C =
0.57 ± 0.10 3 106 M1, Kbap42C = 2.14 ± 0.25 3 10
6 M1).
This was opposite to the expected results for an enthalpy-driven
reaction, which is the usual case with noncovalently binding
MSAs (Buey et al., 2005; Matesanz et al., 2008), and similar to
the behavior observed with CS binding to MTs (Edler et al.,
2005).
In order to check blocking of the taxane pore binding site in
MTs, 200 nM PTX binding sites in stabilized MTs preincubated
with 200 nM 7-Hexaflutax (which binds to the pore site [Bara-
soain et al., 2010]) were incubated with ZMP. No 7-Hexaflutax
was bound in the presence of ZMP at concentrations at least
stoichiometric with the tubulin, indicating that binding of ZMP
to the MTs blocked access to the pore site.
Kinetics of Binding of ZMP and DAC to the PTX Site
in MTs
The kinetics of binding of ZMP and DAC were studied both by
high-performance liquid chromatography (HPLC) (measuring un-
reacted compound) and fluorescence methods (monitoring the
decrease in available binding sites for Flutax-2) (Figure 2D).Ltd All rights reserved
Figure 2. Biochemical Characterization of
the Ligand-Tubulin Interaction
(A) Stoichiometric MT assembly induced by ZMP.
MT assembly in PEDTA6-1 mM GTP buffer with
increasing concentrations of ZMP at 37C. Inset
shows a representative electron micrograph of
a ZMP-induced MT. Error bars indicate the SEM.
Scale bar, 100 nm.
(B) Stoichiometric reaction of ZMP (circles) or DAC
(squares) with glutaraldehyde-stabilized MTs.
Ligand in the supernatant represents compound
that has not reacted with the PTX sites in the
glutaraldehyde-stabilized MTs.
(C) Representative competition experiments
between Flutax-2 and MSAs for binding to MTs.
Displacement of Flutax-2 (50 nM) fromMT binding
sites (50 nM) byZMP (black line and symbols), DCX
(red line and symbols), epothilone A (green line and
symbols), and DAC (blue line and symbols).
(D) Kinetics of the reaction of the ligands with MTs.
Circles, remaining Flutax-2 binding sites when
incubated with DMSO (black), natural ZMP (cyan),
synthetic ZMP (green), and DAC (red). Squares,
unreacted DACwhen incubated with buffer (black)
or stabilized binding sites in MTs (red). Solid black
line, fit of the decay of binding of sites incubated
with DMSO; solid red line, fit of the decay of
binding of sites incubated with DAC; dashed red
line, fit of the decay of unbound DAC when incu-
bated with sites; solid green line, fit of the decay of
binding of sites incubated with ZMP.
See also Table S1.
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Zampanolide Mechanism of ActionThese two experiments were designed to monitor two different
processes and thus to provide an estimate of the kinetics of
the covalent reaction once the compound was noncovalently
bound to the binding site. In the first case, MTs were pelleted
and the concentration of unreacted compound measured, so
both covalently reacted compound and noncovalently bound
compound were pelleted, and thus the measurement accounts
for the kinetics of the noncovalent binding reaction. The second
experiment measured the binding sites that had not yet reacted
and so were available for exchange with Flutax-2. In this case,
the kinetics of the covalent reaction was measured. If the cova-
lent reaction between the compound and the sites was imme-
diate, no difference should be observed between the two
measurements. However, if the reaction was slow and the non-
covalently bound compound could exchange with unbound
compound, a significant difference between measurements
should be observed.
ZMP rapidly reacted with MTs, and the covalent reaction was
complete within 30 min. No differences were observed between
the two measurements, indicating that the covalent reaction
immediately follows noncovalent binding. In contrast, a signifi-
cant difference was observed between the Flutax-2 exchange
and HPLC measurements of the kinetics of DAC binding to
MTs. The covalent reaction with DAC was slower than that of
ZMP, with an apparent kinetic rate constant on the order of
0.12 hr1 (as measured by Flutax-2 exchange), while the nonco-
valent reaction as measured by HPLC was 10 times faster
(apparent kinetic rate constant of the order of 1 hr1) than the
covalent reaction. This indicates a significant delay in the cova-Chemistry & Biology 19,lent reaction of DAC with the binding site following formation of
the noncovalent complex and suggests that the noncovalently
bound compound is in fast exchange with the medium.
ZMP and DAC React with the Luminal Binding Site
of MTs and Dimers
To characterize the interaction of ZMP and DAC with MTs and
dimers, targeted mass spectroscopy (MS) experiments using
a hybrid triple-quadruple mass analyzer were performed.
Specific ion filtering of the ZMP- or DAC-tubulin adducts was
carried out by precursor ion scanning (PIS) experiments using
476m/z as the diagnostic ion for the ZMP-derived tryptic peptide
(see Supplemental Information).
The comparative study between the corresponding PIS chro-
matographic runs pinpointed the ZMP and DAC binding sites
(Figure 3A, highlighted area); some chromatographic peaks
looked altered after the reaction but showed the same mass
composition. The comprehensive analysis of theMS/MS spectra
of these ions revealed the b-tubulin-derived peptide spanning
sequence 219-LTTPTYGDLNHLVSATMSGVTTCLR-243 as the
ZMP and DAC reactive site in MTs (Figure 3B).
To pinpoint the reactive residue, we performed high-resolution
MS (HRMS) analyses in the Orbitrap Elite system. N228 and
H229 were determined to be the residues that reacted with
both DAC and ZMP (Figures 4A and 4B, respectively). The
expanded areas demonstrate that there are two possibilities
for the doubly charged fragment ion y15 depending on whether
N228 or H229 is the modified residue, with the rest of the y ions
common to both adducts. If N228 bears the adduct, then the686–698, June 22, 2012 ª2012 Elsevier Ltd All rights reserved 689
Figure 3. MS Analyses of DAC and ZMP Binding to MTs
(A) Total ion chromatogram (TIC) of the PIS experiment at selectedm/z values for control MTs (gray tracings) orMTs treatedwith compounds (white tracings) DAC
(left) or ZMP (right) in the triple-quadrupolemass spectrometer. The chromatograms are very similar except for subtle differences in the hydrophobic region (black
boxes in the chromatograms). These differences are highlighted in the corresponding expanded areas, which display some differential masses corresponding to
tubulin-derived tryptic peptides bound to DAC (left) or ZMP (right).
(B) Fragmentation MS/MS spectra for the tubulin-derived tryptic peptides bound to DAC (left) or to ZMP (right) as obtained in a low-resolution triple quadrupole
system. Signals correspond to peptides with four charges (z = 4). Squared numbers correspond to DAC or ZMP fragments. The b-tubulin-derived tryptic peptide
219-LTTPTYDGLNHLVSATMSGVTTCLR-243 contains the DAC and ZMP interaction domain. Some of the main fragments from the y-carboxy fragmentation
series are labeled.
See also Figure S1.
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Zampanolide Mechanism of Actionvalue for the doubly charged y15 ionmust be 788.40 Da, for both
DAC and ZMP. In contrast, the value for this ion must be
980.50 Da (for DAC) or 1036.03 (for ZMP) if the modified residue
is H229. The existence of ions y15(A) and y15(B) indicates that
both the H229 and the N228 modifications, respectively,
occurred and the two y15 fragments are clearly detected in the
MS2 spectra, although y15(A) is significantly stronger than
y15(B).690 Chemistry & Biology 19, 686–698, June 22, 2012 ª2012 ElsevierWhile we observed only one labeled peak with ZMP (not
shown), indicating that both adducts coelute, for DAC we iso-
lated three peptides that eluted differently in the HPLC, suggest-
ing three reaction modes (Figure 4C). The first peak eluted at
73 min, the second and most prominent peak at 81 min, and
the third, which was very weak, at 86 min. All these species
spanned the 219–243 sequence, but while peaks 1 and 2 were
labeled at N228 and H229, peak 3 was only labeled at H229.Ltd All rights reserved
Figure 4. MS Characterization of the DAC and ZMP Tubulin Adducts and Reaction Modes of the Compounds with Unassembled Tubulin
and MTs
(A and B) High-resolution MS/MS spectra (R = 30,000) for the triply-charged tubulin-derived trytic peptides bound to DAC (A) or ZMP (B) acquired on the Orbitrap
Elite mass spectrometer. The asterisk marks the mass increase in the y ions bearing the bound molecule (DAC or ZMP). Water losses are labeled with the
symbol o. Some ions corresponding to the accompanying a series are marked with an arrow. The value of z indicates the charge state on each fragment. Detailed
information about the key fragment ions (in the y series), documenting the precise modified residue (N228 or H229), is presented.
(C) DAC interaction with dimeric tubulin, oligomeric tubulin, and MTs. Extracted ion chromatograms (XIC) for the triply charged tubulin-derived tryptic peptide of
the DAC-treated samples at m/z 1012.18823 and 1012.51504.
(D) ZMP interaction with dimeric tubulin, oligomeric tubulin, and MTs. Selected reaction monitoring assays (SRM): the mass of the expected triply charged
b-tubulin ion was monitored in quadrupole 1 (Q1), and two different transitions were studied in quadrupole 3: 476 m/z (from ZMP fragmentation) or 492 m/z
(ion y4).
See also Figure S2.
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Zampanolide Mechanism of ActionHowever, as indicated by a high-resolution fragmentation spec-
trum (Figure S2), the mass of the N-DAC residue in the 73 min
peptide was 1 Da lower than the expected mass of the adduct
observed in the 81 and 86 min peptides.Chemistry & Biology 19,The reaction of ZMP and DAC with unassembled tubulin was
also studied. Both ZMP and DAC reacted with dimeric and olig-
omeric tubulin in less than 4 hr (data not shown). MS analysis of
the adducts (Figures 4C and 4D) revealed that the compounds686–698, June 22, 2012 ª2012 Elsevier Ltd All rights reserved 691
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Zampanolide Mechanism of Actionreacted at the same residues (N228 and H229) as with MTs, indi-
cating that the binding site was also present in unassembled
tubulin. However, while the reaction with ZMP was fast and
extensive, the reaction with DAC was weaker and required
longer incubation times, as had also been the case with MTs.
The ZMP adduct with unassembled tubulin was the same as
that observed with MTs, indicating that the reaction mode is
similar whatever the association state of the protein. However,
this was not the case with DAC. With MTs, three different reac-
tion products with DAC were observed by HPLC, while with
dimeric and oligomeric tubulin the 73 min peptide was not
present. Moreover, the proportions of the 81 and 86 min
peptides varied with the aggregation state of tubulin. With oligo-
meric tubulin (formed with 1.5 mM Mg2+), the DAC adduct at
81 min was the major component; with dimeric tubulin (in the
absence of Mg2+), the major product was the 86 min adduct
modified at H229.
Bioactive Conformation of DAC Bound to MTs
The bioactive conformation and the binding site of DAC bound to
the tubulin a,b-heterodimer and to MTs were determined using
ligand-based NMR techniques. These methods (mainly trans-
ferred nuclear Overhauser effect (TR-NOESY) (Ni and Zhu,
1994) and saturation transfer difference (STD) (Mayer andMeyer,
2001)) rely on the existence of a dissociation rate that is fast on
the relaxation time scale. Therefore, since the irreversible reac-
tion of DAC with tubulin is rather slow (k = 0.12 hr1) as
compared with the reversible reaction (k = 1 hr1), the TR-
NOESY and STD signals obtained should mainly arise from
DAC not yet covalently bound to MTs or dimers. The intensity
of DAC signals in the 1H 1D-NMR spectra slowly decreased
with time at a kinetic rate similar to that determined for the irre-
versible reaction (k = 0.12 hr1), as expected when the ligand
reacts with tubulin, indicating blocking of the binding site. This
situation was not observed for DCX or discodermolide binding
to MTs or tubulin dimers (Canales et al., 2011).
STD-NMR experiments detect saturation transfer from a given
target protein to a bound ligand. Only bound ligands show STD
signals and, as in any NOE-type experiment, the observed STD
effect depends on the distance between the protein and ligand
protons, thus providing a useful tool to detect the ligand epitope.
Binding of DAC to MTs in D2O, 10 mM KPi, 0.1 mM GMPCPP (a
slowly hydrolyzable GTP analog that specifically stabilizes MTs
[Jime´nez-Barbero et al., 2006]), 6 mM MgCl2, pH 7.0, could be
easily detected by STD (Figure 5A). A comparison of the STD
profiles of DAC bound to unassembled tubulin and to MTs indi-
cated that the binding epitopes were nearly identical, which was
not the case for DCX but was the case for discodermolide (Ca-
nales et al., 2011). In both cases with DAC, the STD effect of
all protons was fairly homogeneous throughout the complete
skeleton, thus suggesting an extensive interaction of the mole-
cule with the binding site.
The bioactive conformation of DAC bound to the tubulin
a,b-heterodimer and MTs was deduced by analysis of the TR-
NOESY crosspeaks, as shown in Figure 5B. Several key negative
NOEs between remote protons in the molecule were detected in
the presence of either MTs or unassembled tubulin (Figure 5C,
table), allowing the determination of the bioactive conformations.
The obtained distances indicated that the bound conformations692 Chemistry & Biology 19, 686–698, June 22, 2012 ª2012 Elsevierwere essentially identical in both cases (Figure 5C). Moreover,
2D-ROESY experiments of free DAC in buffer (Figure S3) indi-
cated that the conformation of the compound free in water is
essentially identical, further supporting our determination of the
structure.
Molecular Modeling
In order to rationalize the interaction of ZMP with MTs and
tubulin, the NMR-determined bioactive conformation of DAC
was used to build a ZMP bioactive structure, and both
compounds were docked into the MT luminal site.
Since the covalent reaction occurred at N228 and H229, and
the STD and TR-NOESY signals observed for DAC bound to
MTs arose from free compound just released from its binding
site, we could not assume that the signals observed in the MT-
bound epitope corresponded to the interaction of the compound
with the luminal site, which shows a slow dissociation rate for
MSAs that do not alkylate tubulin, i.e., taxanes (Dı´az et al.,
2000) or epothilones (Dı´az and Buey, 2007). It is more likely
that these NMR signals were caused by a temporary interaction
of DAC with the pore site in MTs, where no covalent reaction
occurred, and fast exchange with the medium would be ex-
pected. On the other hand, the interaction of MSAs with dimeric
tubulin is not yet well characterized and is likely to be nonhomo-
geneous, i.e., binding may involve both the luminal and the
(partial) pore sites (Canales et al., 2011). Therefore, the STD-
determined binding epitope could not be employed to model
ZMP bound to the luminal site. However, since the TR-
NOESY-derived conformation of DAC was identical for binding
to dimers and MTs, it is likely that this conformation is stable
and can be employed as a starting point to find the interaction
with the luminal binding site using standard docking techniques.
The best poses of the ZMP and DAC prereaction complexes
were selected from those with minimal interaction energy, as
calculated from Autodock, and we took into account that at least
one of the likely reactive moieties (the double bond in conjuga-
tion with the ester group, the enone moiety, or the a,b-unsatu-
rated amide moiety of the side chain in the case of ZMP, or the
aldehyde group in the case of DAC) should be close to N228
and/or H229. Those Autodock poses with the a,b-unsaturated
ester moiety close to N228 and the enone moiety (the best
Michael acceptor due to the lack of crossconjugation) close to
H229, were found to be compatible with acceptable dockings
into the PTX site (Figure 6A).
In order to model the adduct with N228, the orientation of the
N228 side chain was then modified to point toward the binding
pocket in order to build the covalent complexes. Considering
the dockings observed, the 1,4-addition most likely involves
the a,b-unsaturated ester moiety within the macrocycle. The
adduct with H229 was modeled without any modification of
the structure.
Given the fact that only onemolecular weight was observed for
the adducts of the reaction of ZMP with MTs, oligomeric tubulin,
and dimeric tubulin, and that the high-resolution spectra indi-
cated that the 73 min peak (see above) was a mixture of DAC-
modified peptides with the adduct at either N228 or H229, the
1 Damass difference between the 73min peak and those eluting
at 81 and 86 min could not be due to inhomogeneities in the
protein sequence but should be related to ligand differences. ItLtd All rights reserved
Figure 5. NMR Characterization of the DAC-
Tubulin Interaction
(A) Off-resonance NMR experiment (600 MHz) (lower line)
and STD spectra (upper line) of DAC bound to MTs.
(B) TR-NOESY spectra (mixing time, 80 ms) of DAC in the
presence of MTs (D2O, 310 K).
(C) Bioactive conformation of DAC bound to MTs. The
table shows the relative intensity of the TR-NOESY NOE
signals between significant protons in the bound
compound.
See also Figure S3.
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performed in NH4HCO3 buffer (Buey et al., 2007), the aldehyde
moiety is partly transformed into the imine. This would generate
a 1 mass difference relative to the aldehyde, which would
account for the peak eluting at 73 min. The different H229
adducts that elute at 81 and 86 min could represent reactionsChemistry & Biology 19, 686–698, June 22with the two different nitrogens of the imidazole
ring of H229, which is probably protonated
under the conditions (pH 6.7) of the experiment
(Matesanz et al., 2008). The most likely reason
for not observing the 81 and 86 peaks in the
analysis of the ZMP adduct is the lower polarity
of the modified peptide due to the ZMP side
chain. This largely increases the retention time
of the adduct that elutes close to the maximum
acetonitrile concentration (90%) (Figure 4D),
thus precluding resolution of both peaks.
DISCUSSION
ZMP, a New Chemotype Targeting the
PTX Binding Site, Indicates the Existence
of the Luminal Site in Unassembled
Tubulin
From a thermodynamic point of view, it is
straightforward that if MSAs bind to MTs, and
not to unassembled tubulin, they will shift the
assembly equilibrium toward MTs. However,
PTX biomimetics induce MT assembly in condi-
tions in which tubulin is normally unable to
assemble, e.g., in the absence of GTP, or even
with GDP bound in the E-site, and thus no
MTs exist (Dı´az and Andreu, 1993; Parness
and Horwitz, 1981). Thus, PTX biomimetics
must play a role in nucleation, presumably by
binding to unassembled tubulin with low affinity,
thereby either inducing a conformational
change that activates tubulin (allosteric mecha-
nism) or joining two subunits to produce a high-
affinity binding site from two low-affinity sites
(matchmaker mechanism) (Dı´az et al., 1993; Re-
ese et al., 2007; Sa´nchez-Pedregal et al., 2006).
Direct binding of ligands to unassembled
tubulin at residue T220 in the pore site has
been observed by MS techniques employing
CS (Buey et al., 2007). NMR and biochemicalstudies have confirmed that DCX and discodermolide bind
with low affinity to dimeric tubulin (Canales et al., 2011). Initial
seminal NMR work from the group of Carlomagno has also
shown low-affinity binding of MSAs to a nonhomogeneous
tubulin preparation (Carlomagno et al., 2003a, 2003b; Sa´n-
chez-Pedregal et al., 2006). However, from these studies it, 2012 ª2012 Elsevier Ltd All rights reserved 693
Figure 6. Molecular Modeling of the
Tubulin-Compound Adducts, Based on the
DAC Conformation Determined by NMR
(A) Model of the ZMP noncovalent prereaction
complex.
(B) Binding model following the covalent reaction
of ZMP with tubulin at N228. The arrow indicates
the C-N bond formed between the ligand and the
Asn side chain.
(C) Binding model following the covalent reaction
of ZMP with tubulin at H229.
(D) Binding model following the covalent reaction
of DAC with tubulin at N228.
(E) Binding model following the covalent reaction
of DAC with tubulin at H229.
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site. Binding at the pore site in unassembled tubulin would indi-
cate that the nucleation mechanism of MSAs is of the match-
maker type (the full pore site would be formed from two half
sites). In contrast, binding at the luminal site in unassembled
tubulin would indicate that the nucleation mechanism is of the
allosteric type (the luminal site is present in a low-affinity confor-
mation that becomes high affinity after assembly (Reese et al.,
2007)). Alternatively, low-affinity binding of anMSA to the luminal
site could in itself induce an allosteric effect, activating tubulin to
induce nucleation.
Our results strongly suggest that the luminal site exists in
unassembled tubulin, since both ZMP and DAC attach to unas-
sembled tubulin and react with residues N228 and H229. Thus,
as previously proposed (Canales et al., 2011; Reese et al.,
2007), MSAs bind to the luminal site in unassembled tubulin,
and not only to the pore site, as was seen with unassembled
tubulin and CS (Buey et al., 2007). These different results with
different MSAs that react covalently with tubulin suggest that
nucleation of MTs may proceed by two alternative mechanisms
(matchmaking and allosteric), as previously discussed (Dı´az
et al., 1993).
Biochemical Mechanisms of MT Induction by ZMP:
Covalently Binding MSAs Are Able to Overcome
P-gp-Mediated MDR
Since ZMP binds irreversibly either at position N228 or at posi-
tion H229 of the b-tubulin subunit with a 1:1 stoichiometry, all694 Chemistry & Biology 19, 686–698, June 22, 2012 ª2012 Elsevier Ltd All rights reservedof the compound reacts with the luminal
site. The lack of superstoichiometric
binding, either reversible or irreversible,
indicates no interaction at the pore.
Thus, binding to either site excludes
binding at the other, and thismight involve
a switching element. The absolute lack of
interaction of 7-Hexaflutax with MTs with
covalently bound ZMP indicates that
binding at the luminal site is specific and
alters and/or blocks the pore site, thus
preventing simultaneous binding to it.
As was the case for CS, the covalent
mechanism of action of ZMP and DACovercame the P-gp-mediated MDR mechanism, since the
compound was equally active in the sensitive (A2780) and
MDR cells (A2780AD) (although it cannot be excluded that the
ligands were poor substrates of P-gp). Thus, the design of cova-
lent binders might be a promising strategy to fight this resistance
mode in cancer chemotherapy.
Structure of the Covalent Complexes of ZMP and DAC
and the Structural Basis of the MT-Stabilizing Effect
The possible different complexes between ZMP or DAC and
tubulin were studied using molecular modeling techniques in
order to understand the stabilization effect observed.
The modeling studies of ZMP and DAC with the luminal
binding site of MTs indicated that in both cases the compounds
bound to the bottom of the binding pocket. In the bound state,
dactylolide presents a globular shape that is buried in the binding
site of the protein, concordant with the fact that the observed
STDs are fairly homogeneous. In complex with N228 (Figure 6B),
the north side of the macrolide ring was held in place by the
covalent interaction with N228. It is notable that in this complex
the side chain of ZMP was involved in interactions with N228.
These interactions involve hydroxyl and carbonyl groups of the
side chain forming two hydrogen bonds with both the amide
and the peptide backbone of N228. In addition, the carbonyl of
N228 formed a hydrogen bond with H229, as did the hydroxyl
of the side chain with S232. Both interactions enhanced the
stability of the resulting complex. The opposite face of the
ZMP side chain maintained contact with the lateral side of
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eastern side of the ZMP macrolide established a strong interac-
tion with R278 in the S7-H9-loop (M-loop) in a manner similar to
that observed for PTX, while thewestern side of themacrolide lay
over H7. The methylene moiety at position 13 occupied a hydro-
phobic pocket between the H7, S9–S10 loop and the M-loop
formed by A233, F272, P274, T276, and L371. In the case of
the complex with H229 (Figure 6C), the interactions observed
were essentially identical, except for those established with the
side chain of N228, which in this complex pointed toward the
E-site nucleotide, and the presence of an additional H-bond
between the hydroxyl of the side chain of ZMP and K19.
In the complex of DAC bound to N228 (Figure 6D), the orienta-
tion of the macrolactone ring was inverted compared with the
ZMP ring (note that the natural product (+)-DAC is the enan-
tiomer of the compound used in this study). Although the north
side was held by the covalent interaction with N228, in this
complex, R278 interacted with the oxygen of the ester. The
eastern side of the molecule was in contact with the bottom of
the binding site, filling the space that the side chain occupied
in the complex with ZMP (Figure 6B). In this case, the methylene
moiety at position 13 interacted directly with the S9–S10 loop
and occupied a small pocket formed by K19, E22, V23, R369,
and G370. In the complex with DAC bound to H229, the ligand
was slightly displaced, being closer to the M-loop (Figure 6E),
with the methylene moiety interacting with the hydrophobic
pocket formed by A233, S236, F272, P274, P360, and S374,
which results in an additional strong interaction with the
M-loop between the aldehyde and Q281.
Finally, our model explains the strong MT-stabilizing activity
observed with ZMP. Covalent binders are missing a property
common to other MSAs. With the epothilones, taxanes, and dis-
codermolide, theMSA binds tighter to theMTs than to unassem-
bled tubulin (Canales et al., 2011; Dı´az et al., 1993). Thus, the
higher free energy of binding toward the assembled species
will shift the assembly equilibrium toward it (Wyman and Gill,
1990), independent of the structural effect on the assembled
species. However, in the case of covalent binders, the equilib-
rium has to be displaced through a structural allosteric effect,
i.e., the modified tubulin should have a higher affinity for the
MT than does the unmodified tubulin. In the case of taxanes,
the strong stabilization of the S7–H9 loop has been described
as the main structural MT-stabilizing feature after taxane binding
(Amos and Lo¨we, 1999; Lo¨we et al., 2001; Nogales et al., 1999). A
similar mechanismmay be the reason for the strongMSA activity
observed with ZMP. In the case of CS, the other MSA with
a covalent mechanism of action (which partially reacts with the
pore site in MTs and thus does not interact with the M-loop in
this binding pose), the observed stabilizing effect is weaker
(Buey et al., 2007; Edler et al., 2005).
SIGNIFICANCE
Zampanolide (ZMP), a new, strong microtubule-stabilizing
agent (MSA) acting at the paclitaxel (PTX) site, exerted its
action through covalent binding to the luminal site of micro-
tubules (MTs) at N228 or H229. Due to its covalent mecha-
nism of action, ZMP was able to overcome P-gp-mediated
multidrug resistance, as also occurred with cyclostreptin.Chemistry & Biology 19,In contrast to cyclostreptin, however, ZMP and dactylolide
(DAC) also reacted with the same residue in unassembled
tubulin, thus providing the first direct evidence of the exis-
tence of the luminal site in dimeric tubulin. Formation of
MTs with ZMP, including the covalent reaction with N228
or H229, required Mg+2 ions at mM concentrations, as is
the case for assembly of tubulin in the presence of taxanes.
The MTs formed with ZMP had normal morphology, despite
formation of the covalent bond, and this indicated a taxane-
like stabilization mechanism. Molecular modeling of the
tubulin-ZMP complex, employing an NMR-determined
bioactive DAC conformation, indicated that the side chain
of ZMP stabilized the covalent adduct. The modeling
provided a structural explanation for the stronger activity
of this compound compared with DAC and indicated that
the stabilization mechanism was due to an allosteric effect
through interactions of the ligand with the M-loop, as is
the case for other MSAs that bind in the PTX site.
EXPERIMENTAL PROCEDURES
Proteins and Ligands
Purified calf-brain tubulin and chemicals were prepared as before (Andreu,
2007; Dı´az and Andreu, 1993). Stabilized, moderately crosslinked MTs were
prepared as before (Dı´az et al., 2000, 2003).
PLA was isolated from Mycale hentscheli collected from Pelorus Sound,
New Zealand. Natural ZMP (Figure 1) was isolated from Cacospongia mycofi-
jiensis collected from ’Eua and Vava’u, Tonga as described (Field et al., 2009).
()-DAC (Figure 1) was prepared as before (Zurwerra et al., 2010). The
synthetic conversion of ()-DAC into ()-ZMP followed the strategy of Hoye
and Hu (2003), with subsequent separation of the resulting C20 epimers by
preparative RP-HPLC. Details of this work will be presented elsewhere. All
spectroscopic properties of synthetic ()-ZMP were identical to those of the
natural product. Aliquots of the compounds were dried to constant weight
and dissolved in spectroscopic ethanol (Merck, Darmstadt, Germany). Their
extinction coefficients (ZMP, ε230 = 31,000 ± 800 M
1 cm1, ε264 = 42,400 ±
1,000 M1 cm1; DAC, ε230 = 15,700 ± 300 M
1 cm1, ε278 = 15,500 ±
300 M1 cm1) were determined in a Thermo Fisher Evolution 300 UV/Vis
spectrometer. The extinction coefficients of ZMP were found to be 30%
higher than those previously determined, ε230 = 25,000 M
1 cm1, ε264 =
30,000M1 cm1 (TanakaandHiga,1996). The ε278of ()-DACwascomparable
with that of (+)-DAC at ε266 (16,000 M
1 cm1); that at 230 nm was 30% higher
than that of (+)-DAC at 222 nm (11,000M1 cm1) (Cutignano et al., 2001). Both
observed ()-DAC peaks were shifted toward red compared with those of the
enantiomer. Drugswere stored as 20mMstocks at80C in dimethyl sulfoxide
(DMSO) and analyzed as described in the Supplemental Information.
Inhibition of [3H]PTX and [3H]PLA Binding to MTs
The inhibition of [3H]PTX and [3H]PLA binding to MTs was measured as
described (Edler et al., 2005), with modifications (see Supplemental Experi-
mental Procedures).
Biochemical Characterization of the Ligand-Tubulin Interaction
Crs of ligand-induced tubulin assembly were measured as before (Buey et al.,
2005). Polymer structureswere checked by transmission electronmicroscopy,
as described in Supplemental Experimental Procedures. The apparent binding
constants of the ligands to the PTX site in MTs were measured by Flutax-2
displacement (Buey et al., 2005). Blocking of the pore site in assembled MTs
was verified by displacement of 7-Hexaflutax, as described for Flutax-2
(Buey et al., 2005), employing 200 nM concentrations of 7-Hexaflutax and sites
due to the lower binding affinity of the compound to MTs (Barasoain et al.,
2010). Reaction stoichiometry was calculated by incubating increasing
amounts of ZMP and DAC with 25 mM PTX binding sites in stabilized MTs in
GAB buffer containing 0.1 mM GTP for 1 hr (ZMP) or at least 4 hr (DAC) at
37C.MTs and the irreversibly bound ZMP or DACwere harvested by pelleting686–698, June 22, 2012 ª2012 Elsevier Ltd All rights reserved 695
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TLX centrifuge. PTX (10 mM) was added to the collected supernatant as an
internal standard. Unreacted ligands were extracted from the supernatant
three times with one reaction volume of CH2Cl2. The extract was dried, and
the sample was resuspended in 70% methanol-30% water (35 mL). The
samples were analyzed as described in the Supplemental Information.
Kinetics of Reaction of the Ligands with Dimeric Tubulin and MTs
The kinetics of reaction of compounds with crosslinkedMTs wasmeasured by
determining the inhibition of Flutax-2 binding to MTs. PTX binding sites (5 mM)
in crosslinked MTs in GAB 0.1 mM GTP were incubated with 6 mM test
compound (or an equivalent volume of DMSO). At the desired time, 10 mM
Flutax-2 was added, and the samples were centrifuged as described above.
The amounts of Flutax-2 in the pellet and supernatant weremeasured spectro-
fluorometrically (Dı´az et al., 2000).
The kinetics of the reaction of the compounds with crosslinked, stabilized
MTs and with unassembled tubulin were also measured by HPLC. Tubulin
(25 mM) in 10 mM NaPi, 1 mM EDTA (pH 7.0) buffer (PEDTA) containing
0.1 mM GTP or in PEDTA containing 1.5 mM MgCl2 and 0.1 mM GTP, or
25 mM crosslinked MTs in GAB with 0.1 mM GTP was incubated with 20 mM
compounds for different times. Unreacted compound was extracted from
the supernatant three times with one reaction volume of CH2Cl2. The extract
was dried, and the sample was resuspended in 70% methanol/30% water
(35 mL). The samples were analyzed as described in the Supplemental
Information.
NMR Experiments
NMR samples of the ligands bound to dimeric and oligomeric tubulin and MTs
were prepared as before (Canales et al., 2011). NMR spectra were recorded at
298 K (dimeric and oligomeric tubulin samples) or 310 K (polymeric tubulin
samples) in D2O in an AV-III 700 MHz equipped with a triple-channel cryo-
probe, an AVANCE 600 MHz equipped with a triple-channel cryoprobe, or
an AVANCE 500 MHz Bruker spectrometer, as previously reported (Canales
et al., 2011). 2D-transverse ROESY experiments were performed as described
(Canales et al., 2008).
The bioactive conformation of DAC was obtained by combining NMR data
with molecular mechanics calculations. TR-NOESY experiments were
acquired with different mixing times from 80 to 200 ms, and the spectrum
with the shortest mixing time was selected for analysis to minimize spin diffu-
sion effects. The calculations were performed using the MacroModel/Batch-
min package (version 9.6) (Schro¨dinger, LLC, 2011a) and the OPLS2005
all-atom force field as implemented in the program MacroModel 9.6 (Schro¨-
dinger, LLC, 2011a). Bulk water solvation was simulated using Macromodel’s
generalized Born GB/SA continuum solvent model. Conformational searches
were carried out using the torsional sampling MCMM search method imple-
mented in the Batchmin program, and 20,000Monte Carlo step runs were per-
formed. The lowest-energy conformer in agreement with the experimental
NOEs was selected as representative of the bound conformation.
Molecular Modeling
The conformational search and docking calculations were performed as previ-
ously described for studying the interaction of taxanes with tubulin (Canales
et al., 2011), employing the bioactive conformation of the DAC ring and consid-
ering free all possible torsional angles of the ZMP side chain. The choice of the
best pose for each ligand (DAC and ZMP) wasmade using the scoring function
of Autodock4.2 (Morris et al., 1998) taking into account the spatial arrange-
ment of the reactive moieties with respect to N228 and H229. Later, the
docked poses chosen wereminimized by usingMacromodel 9.9 (Schro¨dinger,
LLC, 2011a) through several steps of Polak-Ribie`re conjugate gradient until the
energy gradient became lower than 0.05 kJ A˚1 mol1. The top five binding
poses of each ligand were rescored based on a binding free energy approach
implemented in Prime3.0 (Schro¨dinger, LLC, 2011b). A brief overview of these
methods is described in the Supplemental Experimental Procedures.
Nano-Liquid Chromatography and Tandem Mass Spectrometric
Analysis of Tryptic Peptides
Tubulin (20 mM in GAB, 1mMGTP buffer) was assembled at 37C for 1 hr in the
presence of 25 mM ZMP, DAC, or DMSO (vehicle). Unassembled tubulin696 Chemistry & Biology 19, 686–698, June 22, 2012 ª2012 Elseviersamples were prepared using 20 mM GTP-tubulin in 10 mM NaPi, 1 mM
EDTA, 0.1 mM GTP (pH 7.0), without (dimeric tubulin) or with (oligomeric
tubulin) 1.5 mM MgCl2 and 25 mM ZMP, DAC, or DMSO (vehicle). The aggre-
gation state of the tubulin was checked using a Beckman Optima-XLA centri-
fuge. The experiments were performed at 20C and 37C using an angular
velocity of 45,000 rpm. Double sector cells of 12 mm optical path were em-
ployed in an An50Ti rotor. The sedimentation coefficients were calculated
using SEDFIT (Schuck, 2000) and were corrected to 20C using SEDNTERP
(Laue et al., 1992). Both MTs and unassembled tubulin were processed and
digested with trypsin (sequencing grade, Promega, Madison, WI). The diges-
tion solutions were vacuum-dried and dissolved in buffer A (5% acetonitrile,
0.5% acetic acid in water) as described (Buey et al., 2007).
For the ion filtering experiments, the resulting tubulin-derived tryptic
peptides from control and ZMP- or DAC-treated samples were on-line injected
onto a C18 reverse-phase microcolumn (300 mm ID 3 5 mm PepMap, LC
Packings, Amsterdam, The Netherlands) to remove salts and analyzed as
before (Buey et al., 2007) (see Supplemental Information for the detailed setup
of the PIS, selected reaction monitoring, and HRMS analysis). All chromato-
grams and MS/MS spectra were analyzed by the software packages Analyst
1.5.1 (Applied Biosystems, Carlsbad, CA) for the PIS experiments or Proteome
Discoverer 1.3.0.339 (Thermo Fisher, Waltham, MA) for the HRMS data.
Cell Biology Studies
Human A549 non-small-cell lung carcinoma and A2780 and A2780AD ovarian
carcinoma cell lines were cultured as before (Buey et al., 2007). Indirect immu-
nofluorescence and cell-cycle experiments were performed as before (Buey
et al., 2005). Cytotoxicity assays were performed using the MTT (3-(4,5-dime-
thylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) cell proliferation assay
modified as before (Yang et al., 2007).SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
Supplemental Results, one table, and three figures and can be found with
this article online at doi:10.1016/j.chembiol.2012.05.008.
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